CIK 0000818686
- Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 39148213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- 4 Derivatives Options or other derivatives
- 4 Planned sale EVP, Business Development sold 41,658 shares at $35.58 ($1,482,367)
- 4 Planned sale EVP, Chief Financial Officer sold 153,251 shares at $35.61 ($5,457,375)
- 4 Open-market sale Chief Accounting Officer sold 10,679 shares at $36.00 ($384,444)
- 4 Open-market sale EVP, Europe Commercial sold 30,000 shares at $35.40 ($1,062,000)
- 4 Open-market sale Sabag Mark sold 144,180 shares at $34.99 ($5,045,118)
- 4 Open-market sale EVP, U.S. Commercial sold 21,258 shares at $35.31 ($750,620)
- 4 Open-market sale Sabag Mark sold 62,102 shares at $30.14 ($1,871,816)
- 4 Exercise or conversion Sabag Mark acquired 15,723 shares (option exercise)
- 4 Exercise or conversion EVP, Chief Financial Officer acquired 19,916 shares (option exercise)
- 4 Exercise or conversion Chief Accounting Officer acquired 3,537 shares (option exercise)
- 4 Planned sale President and CEO sold 20,025 shares at $31.67 ($634,160)
- 4 Planned sale EVP, U.S. Commercial sold 7,924 shares at $31.67 ($250,940)
- 4 Planned sale Hughes Eric A sold 9,533 shares at $31.67 ($301,895)
- 4 Planned sale EVP, Europe Commercial sold 17,295 shares at $31.67 ($547,705)
- 4 Planned sale Jover Placid sold 14,150 shares at $31.67 ($448,108)
- 4 Open-market sale Interim Chief Legal Officer sold 1,127 shares at $31.67 ($35,690)
- 4 Planned sale EVP, Global Operations sold 17,295 shares at $31.67 ($547,705)
- 4 Planned sale President and CEO sold 23,393 shares at $32.46 ($759,442)
- 4 Planned sale EVP, Europe Commercial sold 91,345 shares at an average $32.66 ($2,983,517)
Page 3 of 34 · 666 filings